PT  - JOURNAL ARTICLE
AU  - Kokkinos, Peter
AU  - Faselis, Charles
AU  - Pittaras, Andreas
AU  - Samuel, Immanuel Babu Henry
AU  - Lavie, Carl J.
AU  - Ross, Robert
AU  - Lamonte, Michael
AU  - Franklin, Barry A.
AU  - Sui, Xuemei
AU  - Myers, Jonathan
TI  - Stroke Incidence According to Cardiorespiratory Fitness: A Cohort Study of 483,379 Hypertensive Patients
AID  - 10.1101/2023.10.06.23296681
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.10.06.23296681
4099  - http://medrxiv.org/content/early/2023/10/07/2023.10.06.23296681.short
4100  - http://medrxiv.org/content/early/2023/10/07/2023.10.06.23296681.full
AB  - Objectives We assessed stroke incidence in hypertensive patients according to cardiorespiratory fitness (CRF) and changes in CRF.Methods A prospective cohort study of 483,379 US Veterans. Participants completed a maximal standardized Exercise Treadmill test (ETT) performed within the Veterans Affairs medical centers across the United States between 1999 and 2020. None exhibited evidence of unstable cardiovascular disease during the ETT. Participants were stratified into 5 age-and-gender specific CRF categories based on the peak metabolic equivalents (METs) achieved. A subgroup of participants with two ETT evaluations (n=110, 576) were also assigned to 4 categories based on MET changes from the initial ETT to the final ETT. Multivariable Cox models, adjusted for age, and co-morbidities were used to estimate HRs and 95% CIs for stroke risk.Results The mean age ± standard deviation (SD) was 59.4±9.0 years. During the median follow-up time of 10.6 years (5,182,179 person-years), there were 15,925 stroke events with an average annual rate of 3.1 events per 1,000 person-years. In a final adjusted model, relatively poor CRF was the strongest predictor of stroke risk than any other comorbidity (HR: 2.24; 95% CI: 2.10-2.40; P< 0.001). For each 1-MET higher exercise capacity, the risk was 10% lower (0.90, 95% CI 0.90-0.91, p<0.001). Compared to the Least-fit, stroke risk was 23% lower for Low-fit individuals (HR 0.77; 95% CI, 0.73-0.80; p<0.001); and declined progressively to 55% for those in the highest CRF category (HR 0.45; 95% CI 0.42-0.48; p<0.001). We also assessed stroke incidence according to change in CRF. Compared to fit individuals during both evaluations, the risk was 27% higher for those who became unfit (HR 1.27, 95% CI 1.15-1.41, p<0.001), and not significantly different for unfit who became fit (HR 1.10, 95% CI 0.97-1.25, p=0.13).Conclusions Poor CRF was the strongest predictor of stroke incidence in hypertensive patients, regardless of age race, or gender. The association was independent, inverse, and graded for all stroke types. Changes in CRF over time reflected inverse changes in stroke risk, suggesting that risk of stroke can be modulated by improved CRF.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is an existing dataset within the Veterans Affairs Health Care System.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional review board at the Washington, DC, Veterans Affairs Medical Center (IRB Net# 1602164).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe dataset of this study was derived from the ETHOS dataset. Access to this dataset is granted to scientist affiliated with the Veterans Affairs Health Care System.